November 16, 2005
CONTACT: Karen Kreeger
(215) 349-5658
karen.kreeger@uphs.upenn.edu

 

Invitation to Cover

TRANSLATING DISCOVERIES ABOUT DIABETES INTO CARE
In honor of November as American Diabetes Month, Penn’s diabetes researchers will speak about cutting-edge diabetes care and research

Nicole Johnson Baker, Miss America 1999 and international diabetes advocate,
to be Keynote Speaker

WHAT: In observance of American Diabetes Month, the Institute for Diabetes, Obesity, and Metabolism, and the PENN Rodebaugh Diabetes Center, invite you to attend an educational forum. Leading Penn physicians and researchers will talk about the latest diabetes research including:
  • The link between obesity and diabetes
  • Innovative research in type 1 and type 2 diabetes
  • Improved patient care
WHEN: Friday, November 18, 2004
3:30 p.m. - 6:30 p.m.
WHERE: Biomedical Research Building
Ground Floor Auditorium
421 Curie Boulevard
Complementary parking available at the Health Center Garage on Curie Blvd.
WHY:
  • The county of Philadelphia has the highest age-adjusted admission rate for diabetes of all counties in Pennsylvania. The state ranks 15th out of all 50 states for prevalence of diabetes.
  • Of the more than 680,000 hospitalizations in the Philadelphia area in 2003, 13.7% or (94,500 patients) had diabetes listed as one of the first five diagnosis codes.
  • An estimated 480,000 residents in the Philadelphia region have been diagnosed with diabetes.

Source: Diabetes Hospitalization Report, Pennsylvania Health Care Cost Containment Council, November 2004; National Center for Chronic Disease Prevention and Health Promotion

Agenda:

Welcoming Remarks by Dr. Arthur H. Rubenstein, Executive Vice President of the University of Pennsylvania for the Health System and Dean of the School of Medicine

Keynote Speaker: Nicole Johnson Baker, Miss America 1999, international diabetes advocate, and author of Living With Diabetes

Panel presentations

  • Mitchell A. Lazar, MD, PhD, Director of the Institute for Diabetes, Obesity, and Metabolism; Professor of Medicine and Genetics; and Chief of the Division of Endocrinology, Diabetes, and Metabolism
  • Michael R. Rickels, MD, Assistant Director, Type 1 Diabetes Unit, Instructor of Medicine, Division of Endocrinology, Diabetes, and Metabolism
  • Nayyar Iqbal, MD, Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism
  • Mark H. Schutta, MD, Medical Director, Penn’s Rodebaugh Diabetes Center

Videotaped message from Patti LaBelle, entertainer, well-known diabetes spokesperson, and Penn diabetes patient

About Penn’s Diabetes Research, Patient Care, and Education Programs
Penn’s Rodebaugh Diabetes Center is the only comprehensive diabetes center in the Philadelphia metropolitan region, providing its patients access to the most sophisticated diagnostic and treatment modalities through a personalized, family-centered team approach. Our patients and their families receive attention individually and through group interaction from certified instructors on topics such as nutrition, medications, exercise, glucose monitoring, coping with a chronic disease, and the prevention of complications.

PENN Medicine has been recognized as one of the top 10 medical institutions in the country for diabetes research. The Institute for Diabetes, Obesity, and Metabolism fosters a collaborative and interdisciplinary environment for translating discoveries about diabetes and its complications into clinical practice.

Please contact Karen Kreeger at (215) 349-5658 or karen.kreeger@uphs.upenn.edu if you plan to attend.

###

PENN Medicine is a $2.7 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn’s School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report’s most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System comprises: its flagship hospital, the Hospital of the University of Pennsylvania, consistently rated one of the nation’s “Honor Roll” hospitals by U.S. News & World Report; Pennsylvania Hospital, the nation's first hospital; Penn Presbyterian Medical Center; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home health care and hospice.


This release is available online at http://www.uphs.upenn.edu/news/News_Releases/nov05/diabforum.htm